Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2007
06/20/2007EP1796793A2 Novel compounds
06/20/2007EP1796677A2 Method for activating trpv4 channel receptors by agonists
06/20/2007EP1796673A2 Novel pyrimidine compounds, process for their preparation and compositions containing them
06/20/2007EP1663966B1 1,3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases
06/20/2007EP1618104B1 Method for synthesising 5-chloro-1-aryl-4-(4, 5-dicyano-1h-imidazol-2-yl)-3-alkyl-1h-pyrazole derivatives
06/20/2007EP1611094B1 Pyrazole compounds
06/20/2007EP1487824B1 Diamino-pyrimidines and their use as angiogenesis inhibitors
06/20/2007EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/20/2007EP1373253B1 Inhibitors of cyclin dependent kinases as anti-cancer agent
06/20/2007CN1984910A Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders
06/20/2007CN1984904A 3-aryl-5,6-disubstituted pyridazines
06/20/2007CN1984902A 2-substituted pyrimidines, method for their production and their use for controlling pathogenic fungi
06/20/2007CN1984871A Process for preparing nitrooxy esters, nitrooxy thioesters, nitrooxy carbonates and nitrooxy thiocarbonates, intermediates useful in said process and preparation thereof
06/20/2007CN1984660A 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis
06/20/2007CN1982316A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
06/20/2007CN1982306A Alpha-substituted-2-methyl-5-nitro-diazole-1-alcohol derivative with optical activity
06/20/2007CN1321996C Process for preparing 2-iminopyrrolidine derivatives
06/20/2007CN1321644C Process for making substituted pyrazoles
06/19/2007US7232912 For therapy of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
06/19/2007US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents
06/19/2007US7232819 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
06/19/2007US7232817 α- and β-amino acid hydroxyethlamino sulfonyl urea derivatives useful as retroviral protease inhibitors
06/19/2007US7232792 3-heterocyclyl-substituted benzoyl derivatives
06/14/2007WO2007067629A1 Bradykinin 1 receptor antagonists
06/14/2007WO2007066615A1 Novel activator of nuclear orphan receptor and use thereof
06/14/2007WO2007066601A1 Pyridazine compound and use thereof
06/14/2007WO2007065662A2 Trisubstituted quinazolinone derivatives as vanilloid antagonists
06/14/2007WO2007065518A1 Pyridiazinone derivatives for tumour treatment
06/14/2007WO2007065261A1 Plasminogen activator inhibitor-1 inhibitors
06/14/2007WO2006099379A3 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
06/14/2007WO2006034419A3 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof
06/14/2007WO2005051308A3 Methods of treating diseases and disorders by targeting multiple kinases
06/14/2007US20070135507 N-1-[(4-chlorophenyl)]-N-2-{[4-(2{dimethylaminomethyl }phenyl)phenyl]-}-(2R,4R)-4-hydroxypyrrolidine-1,2-dicarboxamide; inhibitors of coagulation factor Xa; thromboembolic diseases; tumors
06/14/2007US20070135502 Heterocyclic compounds and methods of use
06/14/2007US20070135494 Substituted 5-aminomethyl-1H-pyrrole-2-carboxylic acid amides
06/14/2007US20070135492 Cannabinoid receptor 1 antagonists (CB1); use of 1,2,4-tri-substituted imidazoline derivatives in the treatment of obesity; use in combination with lipase inhibitor orlistat or lipstatin
06/14/2007US20070135484 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
06/14/2007US20070135477 Benzimidazole derivatives and their use as protein kinases inhibitors
06/14/2007US20070135468 Pyridyloxyalkanoic acid amide derivatives useful as fungicides
06/14/2007US20070135467 Heterocyclic cetp inhibitors
06/14/2007US20070135464 Antiinflammation agents
06/14/2007US20070135463 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing same
06/14/2007US20070135446 Benzoylguanidlne salt and hydrates thereof
06/14/2007US20070135445 Bicyclic Indolyl Derivatives and Methods for Their Use as Serotonergic Agents
06/14/2007US20070135441 e.g. 6-[4-({4-[(5-chloro-1H-indol-2-yl)sulphonyl]piperazin-1-yl}carbonyl)phenyl]-2-[2-(dimethylamino)ethyl]pyridazin-3(2H)-one; anticoagulant; protease, blood coagulation factor Xa inhibitor; thrombosis, atherosclerotic plaques, restenosis, bypass surgery, cerebral infarction, ischemia and angina
06/14/2007US20070135433 Imidazole derivatives as raf kinase inhibitors
06/14/2007US20070135432 Mitotic kinesin KSP inhibitors; antiproliferative agents; 2-methylpyrimidin-4-ones
06/14/2007US20070135428 Lactam containing cyclic diamines and derivatives as factor xa inhibitors
06/14/2007US20070135426 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; thromboembolic disorder like deep vein thrombosis or pulmonary embolism; pyrazolo[3,4-c]pyridine derivatives; blood coagulation factor (trypsin-like serine protease enzymes) inhibitors
06/14/2007US20070135424 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
06/14/2007US20070135421 e.g. Methyl 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate; GABAA (gamma aminobutiric acid) receptor antagonist; sedative-hypnotic, anxiolytic, muscle relaxant and anticonvulsant; anesthesia
06/14/2007US20070135420 Short-acting benzodiazepines
06/14/2007US20070135418 Compositions and methods relating to novel compounds and targets thereof
06/14/2007US20070135409 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
06/14/2007US20070135404 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia
06/14/2007US20070135403 Substituted 2,5-diaminomethyl-1H-pyrrole compounds
06/14/2007US20070135402 Azetidine ring compounds and drugs comprising the same
06/14/2007US20070135346 Prodrugs of CC-1065 analogs
06/14/2007CA2632217A1 Pyridiazinone derivatives for the treatment of tumours
06/14/2007CA2632212A1 Plasminogen activator inhibitor-1 inhibitors
06/14/2007CA2631438A1 Trisubstituted quinazolinone derivatives as vanilloid antagonists
06/14/2007CA2631037A1 Bradykinin 1 receptor antagonists
06/13/2007EP1795529A2 Process for producing N-(Hetero)Aryl-substituted nitrogen-containing heteroaryl compound
06/13/2007EP1794149A2 Bicyclic amides as kinase inhibitors
06/13/2007EP1794148A1 Novel phthalazinone derivatives, as aurora-a kinase inhibitors
06/13/2007EP1794146A2 Tricyclic anilide spirohydantoin cgrp receptor antagonists
06/13/2007EP1794145A1 Pyrazole compounds useful in the treatment of inflammation
06/13/2007EP1794135A1 Substituted heterocyclic compounds and methods of use
06/13/2007EP1794130A1 Pyrazole compounds useful in the treatment of inflammation
06/13/2007EP1794122A1 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i
06/13/2007EP1794120A2 Peptidase inhibitors
06/13/2007EP1793826A2 Chemical compounds
06/13/2007EP1611122B1 Substituted pyrazole compounds
06/13/2007EP1499623B1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-¬(2-methyl-1h-imidazol-1-yl)methyl|-4h-carbazol-4-one
06/13/2007EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors
06/13/2007EP1326611B1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
06/13/2007EP1000040B1 Il-5 inhibiting 6-azauracil derivatives
06/13/2007CN1980929A 4-substituted piperidine derivatives
06/13/2007CN1980918A Substituted indazoles, compositions containing the same, and the preparation and use thereof
06/13/2007CN1980916A Chemokine receptor binding heterocyclic compounds
06/13/2007CN1980911A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
06/13/2007CN1980899A Quinazolinone derivatives as parp inhibitors
06/13/2007CN1980896A Scalable synthesis of imidazole derivatives
06/13/2007CN1980674A Phthalazine derivatives as parp inhibitors
06/13/2007CN1980665A Pyrazole amide derivatives, compositions containing such compounds and methods of use
06/13/2007CN1978441A Phenylcarbazole-based compound and organic electroluminescent device employing the same
06/13/2007CN1978440A Process for producing N-(hetero)aryl-substituted nitrogen-containing heteroaryl compound
06/13/2007CN1321116C Novel azepane derivatives
06/12/2007US7230116 For use as pesticides, microbicides and herbicides
06/12/2007US7230098 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer
06/12/2007US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
06/12/2007US7230025 Pyrazole derivatives
06/12/2007US7230023 Triazole compound containing a phosphonate group
06/12/2007US7230010 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
06/12/2007US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
06/12/2007US7229995 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis
06/12/2007US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes
06/12/2007US7229986 Melanin-concentrating hormone antagonist
06/12/2007CA2354023C Phenylglycine derivatives
06/12/2007CA2173418C Benzonitriles and benzofluorides